ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281279 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281279; 2) Community: the network communities that were significantly associated with the response to NSC 281279; 3) Molecule: the relationships between components within communities and NSC 281279; 4) MDR: the compounds that were significantly associated with the NSC 281279.

NSC Compound Enrichment Correlation
NSC 88971 Null 0.0219468083770723 0.32573536
NSC 658257 Naphthalen-2-one, 4-[(4-bromophenyl)amino]-1,2-dihydro-1-(hydroxyimino)- 0.0221886141818656 -0.085637227
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.022188614181866 0.30521549
NSC 114346 Null 0.022188614181866 0.31356657
NSC 154948 M-AMSA 0.022188614181866 0.30681874
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.022188614181866 0.3877618
NSC 18805 .gamma.-Thujaplicine 0.022188614181866 0.26245003
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.022188614181866 0.40539969
NSC 300289 Pinafide 0.022188614181866 0.28077022
NSC 33570 Null 0.022188614181866 0.2462135
Total:99  Current:52    [First] [Prev] [Next] [Last]